Ticker
MNKDCompany Name
MANNKIND CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 411.7M | $ 287.72M | 69.89% |
3/31/2025 | $ 410.14M | $ 288.46M | 70.33% |
12/31/2024 | $ 393.84M | $ 289M | 73.38% |
9/30/2024 | $ 464.2M | $ 481.42M | 103.71% |
6/30/2024 | $ 443.84M | $ 470.43M | 105.99% |
3/31/2024 | $ 480.88M | $ 509.29M | 105.91% |
12/31/2023 | $ 475.2M | $ 512.81M | 107.91% |
9/30/2023 | $ 320.33M | $ 381.65M | 119.14% |
6/30/2023 | $ 313.42M | $ 383.16M | 122.25% |
3/31/2023 | $ 298.14M | $ 382.91M | 128.43% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for MANNKIND CORP is calculated as follows: Debt [ $ 123.35M ] / Assets [ $ 95.68M ]
(=) Debt to Assets [ 128.92% ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |